Novachem Lanka Private Limited Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: Novachem Lanka Private Limited Pharmaceutical Import Records from India — 3 Products, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Novachem Lanka Private Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $1.0M Trade | TransData Nexus

Novachem Lanka Private Limited

Pharmaceutical Importer · Sri Lanka · Cardiovascular Focus · $1.0M Total Trade · DGFT Verified

Novachem Lanka Private Limited is a pharmaceutical importer based in Sri Lanka with a total trade value of $1.0M across 3 products in 3 therapeutic categories. Based on 31 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Novachem Lanka Private Limited sources from 1 verified Indian supplier, with Pharmafabrikon accounting for 100.0% of imports.

Novachem Lanka Private Limited — Import Portfolio & Supplier Network

Novachem Lanka Private Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Novachem Lanka Private Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Pharmafabrikon	$2.0M	155	100.0%

Novachem Lanka Private Limited sources from 1 verified Indian supplier across 103 distinct formulations. The sourcing is highly concentrated — Pharmafabrikon accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Novachem Lanka Private Limited Import?

Formulation	Value	Ships
Naltrexone hydrochloride tablets USP	$112.3K	3
Adrenaline injection BP 1MG - 1ML	$107.1K	3
Dexamethasone sodium phosphate	$107.1K	3
Telmisartan tablets 40 MG (telmis 40)	$106.9K	3
Telmisartan tablets 20 MG (telmis 20)	$103.9K	3
Baclofen tablets BP 10MG (baclon-10) -	$81.5K	3
Baclofen tablets BP 5MG (baclon-5) -	$73.1K	6
Lithium carbonate tablets USP 250 MG	$54.0K	4
Baclofen tablets BP 10MG (baclon - 10)	$50.0K	1
Baclofen tablets BP 10MG (baclon-10	$50.0K	1
Baclofen tablets BP 10MG (baclon-10) -	$45.1K	1
Baclofen tablets BP 10MG ( baclon-10-10x10s	$45.0K	1
Baclofen tablets BP 5MG (baclon-5) -	$40.3K	2
Baclofen tablets BP 10MG (baclon-10	$36.0K	2
Naltrexone hydrochloride tablets USP 50MG naldict 1 x 10	$30.3K	2

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Telmisartan	Cardiovascular	$600.0K	12	0.0%	15
2	Dexamethasone	Corticosteroids	$300.0K	6	0.2%	16
3	Clonazepam	CNS & Psychiatric	$101.1K	13	0.1%	17

Novachem Lanka Private Limited imports 3 pharmaceutical products across 3 categories into Sri Lanka totaling $1.0M.

Novachem Lanka Private Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Novachem Lanka Private Limited is a pharmaceutical importer based in Nugegoda, Sri Lanka. The company operates as a wholesaler, sourcing finished pharmaceutical formulations from international suppliers for distribution within Sri Lanka. Their primary focus is on importing a range of pharmaceutical products, including tablets, capsules, syrups, and injections, to meet the domestic demand for various therapeutic categories. The company's office is located at 78/2C Shramadana Mawatha, Nugegoda 10250, Sri Lanka.

2Distribution Network

While specific details about Novachem Lanka's warehouse locations and logistics capabilities are not publicly disclosed, the company is known to import pharmaceutical products through the port of Colombo, which is the main international gateway for goods entering Sri Lanka. This strategic location facilitates efficient distribution across the island, ensuring timely delivery to various regions.

3Industry Role

Novachem Lanka Private Limited functions primarily as a pharmaceutical wholesaler in Sri Lanka's supply chain. By importing finished pharmaceutical formulations from international suppliers, the company plays a crucial role in bridging the gap between global manufacturers and the local market. This position enables them to provide a diverse range of pharmaceutical products to meet the healthcare needs of the Sri Lankan population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Novachem Lanka Private Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Novachem Lanka's sourcing strategy exhibits a high degree of concentration, with all 31 shipments from India supplied exclusively by Pharmafabrikon. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or geopolitical issues affecting trade relations. However, the consistent volume of imports and the exclusive partnership suggest a stable and reliable relationship between Novachem Lanka and Pharmafabrikon. The absence of alternative suppliers indicates a strategic choice to maintain a focused and streamlined supply chain, potentially benefiting from negotiated terms and specialized product offerings.

2Supply Chain Resilience

The resilience of Novachem Lanka's supply chain is closely tied to its exclusive partnership with Pharmafabrikon. The lack of backup suppliers means that any disruption at Pharmafabrikon could significantly impact Novachem Lanka's ability to meet domestic demand. The company's import portfolio includes 103 unique formulations, indicating a diverse product range. However, the heavy reliance on a single supplier for all imports suggests that Novachem Lanka may need to develop contingency plans and explore potential alternative suppliers to enhance supply chain resilience.

Strategic Implications

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

The National Medicines Regulatory Authority (NMRA) is the primary regulatory body overseeing pharmaceutical imports in Sri Lanka. Established under the National Medicines Regulatory Authority Act, No. 5 of 2015, the NMRA is responsible for ensuring the safety, efficacy, and quality of medicines and medical devices in the country. Key legislation governing pharmaceutical imports includes the Medicines (Pricing Mechanism for Medicines) Regulations, which outline the procedures for pricing and importation of medicines. The marketing authorization pathway for Indian generics involves obtaining approval from the NMRA, which includes submitting comprehensive documentation and undergoing evaluation to ensure compliance with Sri Lankan standards. (nmra.gov.lk)

2Import Licensing & GMP

Import licensing requirements in Sri Lanka stipulate that all pharmaceutical products must be registered with the NMRA before importation. This process involves submitting detailed product information, including manufacturing details and quality control measures. Good Manufacturing Practice (GMP) certificates from recognized authorities, such as the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S), are essential for demonstrating compliance with international quality standards. Importers must also obtain wholesale distribution authorization from the NMRA, ensuring that they adhere to the regulatory framework governing the distribution of pharmaceutical products within Sri Lanka. (nmra.gov.lk)

Novachem Lanka Private Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Novachem Lanka's product category focus on cardiovascular, corticosteroids, and CNS & psychiatric medications aligns with prevalent health concerns in Sri Lanka. The significant import value of Telmisartan, a cardiovascular drug, suggests a strategic emphasis on managing hypertension, a common condition in the region. The inclusion of corticosteroids and CNS & psychiatric medications indicates a commitment to addressing a broad spectrum of health issues, including inflammatory conditions and mental health disorders. This product strategy reflects an understanding of the therapeutic needs of the Sri Lankan population and positions Novachem Lanka to meet these demands effectively.

2Sourcing Profile

Novachem Lanka's sourcing strategy is centered on importing generic drugs, primarily from India, which offers a cost-effective and diverse range of pharmaceutical products. The company's preference for finished pharmaceutical formulations, as opposed to raw Active Pharmaceutical Ingredients (APIs) or bulk drugs, suggests a focus on ready-to-market products that can be distributed promptly within Sri Lanka. India's established pharmaceutical manufacturing industry, known for its adherence to international quality standards, aligns with Novachem Lanka's procurement needs, ensuring a reliable supply of quality medicines.

3Market Positioning

Seller's Guide — How to Become a Supplier to Novachem Lanka Private Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Novachem Lanka's supply chain, especially if they can offer competitive pricing, superior product quality, or unique formulations not currently available. The existing concentration on a single supplier, Pharmafabrikon, indicates potential gaps in Novachem Lanka's sourcing strategy that could be addressed by diversifying suppliers. Indian exporters seeking to become alternative suppliers should focus on building strong relationships, ensuring compliance with Sri Lankan regulatory standards, and demonstrating the value they can add to Novachem Lanka's product portfolio.

2Requirements & Qualifications

Indian exporters aiming to supply Novachem Lanka and the Sri Lankan market must obtain GMP certificates from recognized authorities, such as the WHO or PIC/S, to demonstrate compliance with international quality standards. Additionally, they must ensure that their products are registered with the NMRA, adhering to the regulatory framework governing pharmaceutical imports in Sri Lanka. Maintaining up-to-date import licenses and complying with labeling requirements, including displaying the MRP and the name and address of the local MAH or importer, are also essential for market entry. (nmra.gov.lk)

Frequently Asked Questions — Novachem Lanka Private Limited

What products does Novachem Lanka Private Limited import from India?

Novachem Lanka Private Limited imports 3 pharmaceutical products across 3 categories. Top imports: Telmisartan ($600.0K), Dexamethasone ($300.0K), Clonazepam ($101.1K).

Who supplies pharmaceuticals to Novachem Lanka Private Limited from India?

Novachem Lanka Private Limited sources from 1 verified Indian suppliers. The primary supplier is Pharmafabrikon (100.0% of imports, $2.0M).

What is Novachem Lanka Private Limited's total pharmaceutical import value?

Novachem Lanka Private Limited's total pharmaceutical import value from India is $1.0M, based on 31 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Novachem Lanka Private Limited focus on?

Novachem Lanka Private Limited imports across 3 categories. The largest: Cardiovascular (59.9%), Corticosteroids (30.0%), CNS & Psychiatric (10.1%).

Get Full Novachem Lanka Private Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.